辉瑞-生物科技 COVID-19 疫苗接种后神经幻嗅的独特影像学表现：一例报告。
Unique Imaging Findings of Neurologic Phantosmia Following Pfizer-BioNtech COVID-19 Vaccination: A Case Report.
机构信息
Department of Radiology, North Shore University Hospital-Long Island Jewish Radiology Residency, Zucker Hofstra School of Medicine, Northwell Health, Manhasset, NY.
Feinstein Institutes for Medical Research, Institute of Molecular Medicine, Northwell Health, Manhasset, NY.
出版信息
Top Magn Reson Imaging. 2021 Jun 1;30(3):133-137. doi: 10.1097/RMR.0000000000000287.
Olfactory dysfunction related to SARS-CoV-2 infection and COVID-19 disease is now well established in the literature. In December 2020, the FDA approved the Pfizer-BioNTech and Moderna vaccines for use in preventing COVID-19 in the United States. To the best of our knowledge, this is the first report of a phantosmia post-Pfizer COVID-19 vaccination, with positive magnetic resonance imaging radiographic findings in a patient with documented absence of infection by SARS-CoV-2 virus or concomitant sinonasal disease.
嗅觉功能障碍与 SARS-CoV-2 感染和 COVID-19 疾病有关，这在文献中已经得到充分证实。2020 年 12 月，FDA 批准辉瑞-生物技术公司和 Moderna 疫苗在美国用于预防 COVID-19。据我们所知，这是首例辉瑞 COVID-19 疫苗接种后幻嗅的报告，患者磁共振成像显示放射性结果阳性，但经证实未感染 SARS-CoV-2 病毒或同时患有鼻旁窦疾病。
Zotero 插件